Skip to main content
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
1.700
-0.080 (-4.49%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Whitehawk Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
--65.77-60.51-110.09-3.48
Upgrade
Depreciation & Amortization
-0.170.160.110.01
Upgrade
Asset Writedown & Restructuring Costs
--3.7274.16-
Upgrade
Loss (Gain) From Sale of Investments
--3.14-1.22--
Upgrade
Stock-Based Compensation
-11.959.642.110.14
Upgrade
Other Operating Activities
-0.520.38-0.951.14
Upgrade
Change in Accounts Receivable
--3.63-1.8614.15-13.86
Upgrade
Change in Inventory
--3.27-1.86--
Upgrade
Change in Accounts Payable
--0.133.228.291.08
Upgrade
Change in Other Net Operating Assets
-3.62-1.32-10.192.28
Upgrade
Operating Cash Flow
--59.66-49.64-22.42-12.7
Upgrade
Capital Expenditures
--3.97-0.44-0.05-
Upgrade
Cash Acquisitions
---25.2-
Upgrade
Investment in Securities
-87.18-132.44--
Upgrade
Investing Cash Flow
-83.21-132.8925.15-
Upgrade
Long-Term Debt Issued
----1.19
Upgrade
Net Debt Issued (Repaid)
----1.19
Upgrade
Issuance of Common Stock
-0.4973.28155.83-
Upgrade
Preferred Dividends Paid
----4.41-
Upgrade
Dividends Paid
----4.41-
Upgrade
Other Financing Activities
--0.16-0.66-9.62-
Upgrade
Financing Cash Flow
-0.3372.62141.81.19
Upgrade
Net Cash Flow
-23.87-109.91144.53-11.51
Upgrade
Free Cash Flow
--63.64-50.08-22.47-12.7
Upgrade
Free Cash Flow Margin
--261.29%-329.15%-2006.16%-87.11%
Upgrade
Free Cash Flow Per Share
--2.36-2.23-2.52-5.00
Upgrade
Cash Interest Paid
-0.230.23--
Upgrade
Levered Free Cash Flow
--37.7-29.52-15.23-12.2
Upgrade
Unlevered Free Cash Flow
--37.56-29.38-14.81-11.69
Upgrade
Change in Net Working Capital
7.460.751.89-6.1910.25
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.